Diabetes Screening and Diagnosis with HbAlc

LIU Chao,CHEN Li-li

DOI: https://doi.org/10.3760/cma.j.issn.1673-4157.2009.04.006

2009-01-01

International Journal of Endocrinology and Metabolism

Abstract:Hemoglobin AIc (HbAIc) has been used for decades to monitor the glycemic control in diabetic patients. Although HbAIc is currently undergoing a reassessment, and major developments have been underway in recent years, HbAIc is not recommended at present for diabetes screening or diagnosis. In diabe-tes screening and diagnosis, the current diagnostic guidelines use measurement of plasma glucose either fast-ing or after glucose load. These diagnostic methods have shortcomings warranting a potential diagnostic role for HbAlc. Recently,an international committee assembled by the American Diabetes Association (ADA), the European Association for the Study of Diabetes and the International Diabetes Federation is recommending the HbAlc assay as the test for the diagnosis of prediabetes and diabetes. The committee proposes HbAlc of 6.5% or greater as a reasonable cut point, with the best accuracy, sensitivity and specificity. Moreover, the addition of blood glucose test to the HbAlc assay will improve the sensitivity of diagnosis. The committee's recommendation ,which has not yet been officially endorsed by the three diabetes organizations, was first re-ported in the 69th Scientific Session of ADA. This review introduces the confounding factors and standardiza-tion of the HbAlc test ,the evidence supporting HbAle assay for diabetes screening and diagnosis and the cri-teria for the screening and diagnosis using HbAlc combined with blood glucose.